Cevayir Coban Selected Research

Vaccine Adjuvants

1/2022	Anti-tumor immunity by transcriptional synergy between TLR9 and STING activation.
1/2018	DAMP-Inducing Adjuvant and PAMP Adjuvants Parallelly Enhance Protective Type-2 and Type-1 Immune Responses to Influenza Split Vaccination.
12/2011	Novel strategies to improve DNA vaccine immunogenicity.
1/2010	Immunogenicity of whole-parasite vaccines against Plasmodium falciparum involves malarial hemozoin and host TLR9.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Cevayir Coban Research Topics

Disease

20	Malaria 01/2024 - 07/2002
16	Infections 01/2021 - 07/2002
7	Neoplasms (Cancer) 01/2024 - 07/2006
6	Human Influenza (Influenza) 01/2018 - 07/2006
5	Virus Diseases (Viral Diseases) 10/2020 - 10/2005
4	Bites and Stings (Sting) 01/2024 - 12/2011
4	Inflammation (Inflammations) 01/2021 - 03/2015
4	Communicable Diseases (Infectious Diseases) 07/2013 - 01/2009
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022 - 08/2016
2	Asthma (Bronchial Asthma) 01/2019 - 04/2013
2	Hypersensitivity (Allergy) 04/2016 - 06/2010
2	Parasitemia 07/2013 - 01/2007
2	Cerebral Malaria 03/2010 - 01/2007
1	Lung Neoplasms (Lung Cancer) 01/2024
1	Breast Neoplasms (Breast Cancer) 01/2024
1	Disease Progression 01/2024
1	Peritonitis 01/2021
1	COVID-19 10/2020
1	Autoimmune Diseases (Autoimmune Disease) 10/2020
1	Thrombocytopenia (Thrombopenia) 01/2020
1	Epstein-Barr Virus Infections 10/2018
1	Lymphoma (Lymphomas) 10/2018
1	Pneumonia (Pneumonitis) 04/2013
1	Anemia 11/2012
1	Encephalitis (Encephalitis, Rasmussen) 12/2011
1	Animal Diseases 11/2008
1	Porcine Reproductive and Respiratory Syndrome (PRRS) 09/2008
1	RNA Virus Infections 07/2006
1	Melanoma (Melanoma, Malignant) 07/2006
1	Immune System Diseases (Immune Disorders) 01/2006

Drug/Important Bio-Agent (IBA)

13	VaccinesIBA 01/2018 - 01/2004
8	AntigensIBA 01/2018 - 07/2006
8	hemozoinIBA 06/2017 - 07/2002
6	Toll-Like Receptors (Toll-Like Receptor)IBA 12/2011 - 07/2006
5	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 01/2006
5	Interferon Type IIBA 08/2016 - 07/2006
4	Vaccine AdjuvantsIBA 01/2022 - 01/2010
4	DNA VaccinesIBA 07/2013 - 07/2006
3	InterferonsIBA 01/2024 - 10/2005
3	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2004
3	InflammasomesIBA 01/2021 - 03/2010
3	Heme (Haem)IBA 07/2013 - 01/2005
3	A-Form DNA (A-DNA)IBA 12/2011 - 01/2004
2	vadimezanIBA 01/2024 - 01/2013
2	Lipocalin-2IBA 01/2024 - 11/2012
2	Interleukin-12 (IL 12)IBA 01/2022 - 08/2016
2	AntibodiesIBA 01/2020 - 01/2011
2	CPG-oligonucleotideIBA 01/2018 - 01/2004
2	Hemoglobins (Hemoglobin)IBA 06/2017 - 01/2005
2	Nucleic AcidsIBA 09/2008 - 01/2006
2	CytokinesIBA 09/2008 - 07/2006
2	Antiviral Agents (Antivirals)IBA 10/2007 - 01/2006
1	Histones (Histone)IBA 01/2024
1	Immune Checkpoint InhibitorsIBA 01/2024
1	LigandsIBA 01/2024
1	Therapeutic UsesIBA 01/2024
1	Messenger RNA (mRNA)IBA 01/2022
1	Interleukin-12 Subunit p40IBA 01/2022
1	Pyrin Domain-Containing 3 Protein NLR FamilyIBA 01/2021
1	LipopolysaccharidesIBA 01/2021
1	Protein Phosphatase 2 (Protein Phosphatase 2A)IBA 01/2021
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 10/2020
1	quinolineIBA 10/2020
1	Chloroquine (Aralen)FDA LinkGeneric 10/2020
1	Heparin (Liquaemin)FDA LinkGeneric 01/2020
1	Interleukin-33IBA 01/2019
1	cyclic guanosine monophosphate-adenosine monophosphateIBA 01/2019
1	amlexanox (Aphthasol)FDA Link 01/2019
1	Immunoglobulin G (IgG)IBA 01/2019
1	Immunoglobulin E (IgE)IBA 01/2019
1	ParaffinIBA 10/2018
1	RNA (Ribonucleic Acid)IBA 10/2018
1	Pathogen-Associated Molecular Pattern MoleculesIBA 01/2018
1	SpectrinIBA 12/2017
1	Ethylnitrosourea (N-Ethyl-N-nitrosourea)IBA 12/2017
1	Antimalarials (Antimalarial Agents)IBA 06/2017
1	delta inulinIBA 02/2017
1	K3-SPGIBA 08/2016
1	Neoplasm Antigens (Tumor Antigens)IBA 08/2016
1	Hemagglutinins (Hemagglutinin)IBA 03/2015
1	CyclodextrinsIBA 03/2015
1	SandIBA 04/2013
1	IronIBA 11/2012
1	Phosphotransferases (Kinase)IBA 12/2011
1	Plasmodium serine repeat antigenIBA 12/2011
1	Toll-Like Receptor 9IBA 07/2010
1	Hemin (Panhematin)FDA Link 06/2010
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 03/2010
1	Pattern Recognition ReceptorsIBA 09/2008
1	Viral RNAIBA 09/2008
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 07/2006
1	B-Form DNA (B-DNA)IBA 01/2006
1	RNA Helicases (RNA Helicase)IBA 10/2005
1	Small Interfering RNA (siRNA)IBA 10/2005
1	PolymersIBA 01/2005

Therapy/Procedure

2	Immunotherapy 01/2024 - 01/2022
1	Oral Administration 01/2019
1	Therapeutics 06/2017
1	Intravenous Injections 08/2016